| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |